Literature DB >> 9418201

Percutaneous endovascular stent-graft repair of iliac artery aneurysms.

G Dorros1, J M Cohn, M R Jaff.   

Abstract

PURPOSE: To report a percutaneous technique for endovascular repair of iliac artery aneurysms using commercially available materials.
METHODS: Ten patients (9 males; mean age 65 +/- 11 years) presented with 11 isolated iliac artery aneurysms; 3 patients were asymptomatic. Stent-grafts were customized for each patient from polytetrafluoroethylene grafts with Palmaz stents sutured at either end of the tube. The devices were delivered percutaneously through standard 14F sheaths and deployed by balloon dilation.
RESULTS: All iliac aneurysms were excluded without procedural incident. One patient with chronic renal insufficiency (baseline serum creatinine 1.9 mg/dL) experienced transient contrast-induced renal failure inhospital. The average hospital stay was 2.5 days (range 1 to 7). One vessel thrombosed 2 weeks following the procedure; the culprit stenosis at the site of arterial cannulation was dilated. One patient died of myocardial infarction at 6 weeks. The remaining eight grafts are patent and free of endoleak at a mean 14-month follow-up.
CONCLUSIONS: This percutaneous technique appears to be an acceptable alternative to open surgical repair.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418201     DOI: 10.1177/152660289700400409

Source DB:  PubMed          Journal:  J Endovasc Surg        ISSN: 1074-6218


  2 in total

1.  Endovascular treatment of isolated common iliac artery aneurysms with short necks using bifurcated stent-grafts.

Authors:  Jin Wi; Young-Guk Ko; Jung-Sun Kim; Donghoon Choi; Myeong-Ki Hong; Do-Youn Lee; Yangsoo Jang; Won-Heum Shim
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

2.  Endovascular treatment of isolated iliac artery aneurysms: 2-year follow-up.

Authors:  D Laganà; G Carrafiello; C Recaldini; F Fontana; R Caronno; P Castelli; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.